Skip to main content
. 2012 May 9;176(1):1–13. doi: 10.1093/aje/kwr482

Table 4.

Association of Calcium and Vitamin D Supplementation With Measures of Depression at Year 3, According to Vitamin D and Calcium Intake at Baseline, Women’s Health Initiative Calcium and Vitamin D Trial, 1995–2003

Depressive Symptoms (Burnam Score ≥0.06) Use of Antidepressant Medication
No. of Cases Total No. ORa for Supplementation vs. Placebo 95% CI No. of Users Total No. ORa for Supplementation vs. Placebo 95% CI
Total vitamin D intake, IU/dayb
    <100 46 418 0.61 0.30, 1.22 350 4,965 0.89 0.68, 1.16
    100–<200 49 487 2.84 1.38, 5.83 550 7,570 1.20 0.96, 1.49
    200–<400 34 390 1.80 0.82, 3.97 509 6,382 0.96 0.76, 1.21
    400–<600 53 520 0.91 0.49, 1.70 683 8,018 0.92 0.76, 1.13
    ≥600 37 379 0.99 0.47, 2.05 574 6,468 1.09 0.87, 1.36
        Pinteraction 0.03 0.32
Dietary vitamin D intake, IU/day
    <100 70 687 0.88 0.51, 1.52 668 8,989 0.91 0.75, 1.11
    100–<200 76 876 1.46 0.87, 2.44 1,127 14,039 1.10 0.94, 1.28
    200–<400 59 529 1.39 0.76, 2.53 725 8,782 0.96 0.79, 1.17
    ≥400 14 102 0.99 0.29, 3.35 146 1,593 1.13 0.73, 1.76
        Pinteraction 0.55 0.45
Supplemental vitamin D intake, IU/day
    None 127 1,201 1.38 0.91, 2.07 1,296 17,367 1.02 0.89, 1.18
    <400 20 207 1.15 0.43, 3.11 272 3,383 1.04 0.76, 1.43
    400–<800 68 733 1.04 0.61, 1.78 1,038 11,882 0.99 0.84, 1.17
    ≥800 4 53 0.22 0.02, 2.63 60 771 0.86 0.44, 1.69
        Pinteraction 0.48 0.96
Total calcium intake, mg/dayb
    <400 29 221 0.50 0.20, 1.24 146 2,358 0.87 0.58, 1.31
    400–<800 65 655 1.76 0.98, 3.17 661 8,831 1.00 0.82, 1.22
    800–<1,000 24 293 1.81 0.73, 4.48 403 4,682 1.24 0.96, 1.61
    1,000–<1,200 19 244 1.16 0.43, 3.19 301 4,154 0.98 0.73, 1.32
    ≥1,200 82 781 1.05 0.63, 1.73 1,155 13,378 0.97 0.83, 1.14
        Pinteraction 0.18 0.52
Dietary calcium intake, mg/day
    <400 39 380 0.61 0.29, 1.29 318 4,429 0.94 0.71, 1.25
    400–<800 96 932 1.28 0.80, 2.04 1,098 14,298 0.98 0.84, 1.14
    800–<1,000 24 328 2.57 1.01, 6.55 450 5,448 1.15 0.90, 1.47
    1,000–<1,200 24 231 1.03 0.41, 2.60 270 3,526 1.26 0.92, 1.73
    ≥1,200 36 323 1.27 0.59, 2.73 530 5,702 0.90 0.71, 1.13
        Pinteraction 0.21 0.37
Supplemental calcium intake, mg/day
    None 114 1,024 1.28 0.83, 1.99 1,070 14,334 1.00 0.85, 1.17
    <400 47 528 1.47 0.77, 2.82 697 7,987 1.13 0.92, 1.38
    400–<800 29 382 0.97 0.43, 2.19 516 6,342 0.93 0.74, 1.17
    ≥800 29 260 0.80 0.34, 1.88 383 4,740 0.96 0.74, 1.26
        Pinteraction 0.66 0.63

Abbreviations: AD, antidepressant; CI, confidence interval; OR, odds ratio.

a

Multivariable models adjusted for age, race/ethnicity, WHI Hormone Trial intervention, and WHI Dietary Modification Trial intervention. The analysis of risk of depressive symptoms above the threshold level (Burnam score ≥0.06) included adjustment for this variable at year 1. The analysis of risk of antidepressant use included adjustment for antidepressant use at year 1.

b

Total nutrient intake = dietary nutrient intake (assessed at year 0) + supplemental nutrient intake (assessed at year 1).